Company Search:
Advanced Search
Sponsored Links
Veru Inc Company Snapshot
Veru Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Veru Inc with three other companies in this sector in the United States: Advaxis, Inc. (2017 sales of $12.03 million of which 100% was License Fees & Grants), Sunwin Stevia International Incorporation ($19.35 million ), and Elite Pharmaceuticals, Inc. ($9.64 million of which 90% was ANDA).

Sales Analysis. During the year ended September of 2017, sales at Veru Inc were $13.66 million. This is a sharp decrease of 38.3% versus 2016, when the company's sales were $22.13 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Veru Inc
  Stock Performance Chart for Veru Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 1.35
(Figures in U.S. Dollars)
1 Week -8.2%   13 Weeks 8.9%  
4 Weeks -28.2%   52 Weeks 33.7%  
Veru Inc Key Data:
  Ticker: VERU Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 13,655,592
(Year Ending Jan 2018).
Employees: 156
  Currency: U.S. Dollars Market Cap: 71,831,460
  Fiscal Yr Ends: September Shares Outstanding: 53,208,489
  Share Type: Common Closely Held Shares: 25,041,642
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.